16 November 2020 Step up for TB 2020 - Social Media Gallery, Animated Images Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by Susanne Doettling Research article Research article | 21 December 2022 Tropical & neglected diseases Toxicon: X: Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues 1 min Photo credit: Oksana Parafeniuk/MSF Press release Press release | 15 December 2022 Tuberculosis MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis 3 min Letter | 06 December 2022 Vaccines The Lancet Gastroenterology & Hepatology: An open letter to Gavi: hepatitis B birth dose vaccine can't wait Letter | 05 December 2022 Intellectual property and trade Civil Society Open Letter to the Council of the European Union Concerning Transferable Exclusivity Vouchers for Antimicrobials Video Video | 01 December 2022 Working for access to long-acting cabotegravir for HIV prevention Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min Blog Blog | 17 November 2022 How much do clinical trials cost? The answer is overdue. Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Load More
Photograph by Susanne Doettling Research article Research article | 21 December 2022 Tropical & neglected diseases Toxicon: X: Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues 1 min
Photo credit: Oksana Parafeniuk/MSF Press release Press release | 15 December 2022 Tuberculosis MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis 3 min
Letter | 06 December 2022 Vaccines The Lancet Gastroenterology & Hepatology: An open letter to Gavi: hepatitis B birth dose vaccine can't wait
Letter | 05 December 2022 Intellectual property and trade Civil Society Open Letter to the Council of the European Union Concerning Transferable Exclusivity Vouchers for Antimicrobials
Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min